It’s time to start a specific thread on whether the COVID-19 application will proceed.
I think there is enough evidence to suggest the COVID-19 application will not be a goer. The Novartis delay is quite inexplicable given the global emergency.
Sure, there might be some reason for Novartis not proceeding quickly. But absence any clarifying statement it is not clear what that could be. The mystery deepens because of the confidant statement three months or so ago that the announcement would be in a few weeks.
If Novartis walk away, what will that mean for the Covid-19 application?
-
- There are more pages in this discussion • 4,675 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.67 |
Change
0.010(0.60%) |
Mkt cap ! $2.121B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.67 | $1.63 | $2.880M | 1.739M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6204 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 16500 | 2 |
View Market Depth
| Last trade - 15.59pm 14/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |